Investors Secure Class Cert. In Biotech Stock-Drop Case
A California federal judge on Monday certified a shareholder class alleging that biotech company NantKwest didn't tell investors the company had incurred over $114 million in executive compensation expenses for its...To view the full article, register now.
Already a subscriber? Click here to view full article